Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2009

Jan 13, 2009

34519_dirs_2009-01-13_1a5f0824-5961-4548-bd0a-90dcb2464a9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-01-09

Reporting Person: BRIGHAM MICHAEL F (Director, President & CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-01-09 Incentive stock options (right to buy) $1.70 A 47500 Acquired 2019-01-09 common stock (47500) Direct